09th week of 2017 patent applcation highlights part 10 |
Patent application number | Title | Published |
20170056330 | MICROCAPSULE FORMULATION AND METHOD FOR PRODUCING THE SAME | 2017-03-02 |
20170056331 | NOVEL DROPLET-EMBEDDED MICROFIBERS, AND METHODS AND DEVICES FOR PREPARING AND USING SAME | 2017-03-02 |
20170056332 | HEMORRHOID PREPARATION AND SHEETS | 2017-03-02 |
20170056333 | DELIVERY OF ACTIVE AGENTS USING NANOFIBER WEBS | 2017-03-02 |
20170056334 | FAT-BASED FOOD PRODUCTS | 2017-03-02 |
20170056335 | Ophthalmic Composition | 2017-03-02 |
20170056336 | CO-TARGETING ANDROGEN RECEPTOR SPLICE VARIANTS AND MTOR SIGNALING PATHWAY FOR THE TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER | 2017-03-02 |
20170056337 | ANTIBACTERIAL S-HETEROSUBSTITUTED DISULFIDES | 2017-03-02 |
20170056338 | Chocolate with antioxidants | 2017-03-02 |
20170056339 | FORMULATION OF FAT-SOLUBLE VITAMIN | 2017-03-02 |
20170056340 | Composition for Administering an NMDA Receptor Antagonist to a Subject | 2017-03-02 |
20170056341 | Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride | 2017-03-02 |
20170056342 | Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride | 2017-03-02 |
20170056343 | Extended Release Dosage Form Comprising Cyclobenzaprine Hydrochloride | 2017-03-02 |
20170056344 | METHODS OF TREATING LENNOX-GASTAUT SYNDROME USING FENFLURAMINE | 2017-03-02 |
20170056345 | BOOSTER DRUG THERAPY FOR MYCOBACTERIUM INFECTIONS | 2017-03-02 |
20170056346 | METHODS AND COMPOSITIONS FOR TREATING MULTIPLE MYELOMA | 2017-03-02 |
20170056347 | METHODS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH AN ABNORMAL INFLAMMATORY RESPONSES | 2017-03-02 |
20170056348 | Autoimmune Disorder Treatment using RXR Agonists | 2017-03-02 |
20170056349 | Methods for Preventing or Reducing Colon Carcinogenesis | 2017-03-02 |
20170056350 | Targeted Treatment of Anerobic Cancer | 2017-03-02 |
20170056351 | COMPOSITION FOR INDUCING TUMOR IMMUNITY | 2017-03-02 |
20170056352 | PHARMACEUTICALLY ACCEPTABLE SALTS OF beta-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF | 2017-03-02 |
20170056353 | PHARMACEUTICALLY ACCEPTABLE SALTS OF ss-GUANIDINOPROPIONIC ACID WITH IMPROVED PROPERTIES AND USES THEREOF | 2017-03-02 |
20170056354 | TYPE A GELATIN CAPSULE CONTAINING PUFA IN FREE ACID FORM | 2017-03-02 |
20170056355 | PHARMACEUTICAL FORMULATIONS CONTAINING LIPOIC ACID DERIVATIVES | 2017-03-02 |
20170056356 | UTILIZATION OF DIALKYL FUMARATES IN TREATMENT OF HEART FAILURE | 2017-03-02 |
20170056357 | METHOD OF DIETARY TREATMENT FOR GENETIC AND EPIGENETIC DISEASES AND DISORDERS | 2017-03-02 |
20170056358 | FUMARATE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USE | 2017-03-02 |
20170056359 | FUMARATE ESTER DOSAGE FORMS | 2017-03-02 |
20170056360 | FUMARATE ESTER DOSAGE FORMS | 2017-03-02 |
20170056361 | METHODS OF REDUCING THE RISK OF A CARDIOVASCULAR EVENT IN A SUBJECT ON STATIN THERAPY | 2017-03-02 |
20170056362 | SN-2-MONOACYLGLYCEROLS AND LIPID MALABSORPTION | 2017-03-02 |
20170056363 | Method of lowering cholesterol | 2017-03-02 |
20170056364 | METHODS OF TREATING AN OVERWEIGHT OR OBESE SUBJECT | 2017-03-02 |
20170056365 | DAPAGLIFLOZIN COMPOSITIONS | 2017-03-02 |
20170056366 | LIQUID PHARMACEUTICAL COMPOSITIONS COMPRISING SGLT-2 INHIBITORS | 2017-03-02 |
20170056367 | PHARMACEUTICAL COMPOSITIONS FOR INHIBITING THE OSTEOCLAST DIFFERENTIATION COMPRISING EUPATILIN | 2017-03-02 |
20170056368 | CANNABINOID COMPOSITIONS AND USES | 2017-03-02 |
20170056369 | TANNIN-CONTAINING GASTROINTESTINAL FORMULATIONS AND METHODS OF USE | 2017-03-02 |
20170056370 | COMPOSITION COMPRISING 7-HYDROXYMATAIRESINOL | 2017-03-02 |
20170056371 | PHARMACEUTICAL COMPOSITIONS AND METHODS | 2017-03-02 |
20170056372 | USE OF PRODRUGS OF FUMARATES IN TREATING HEART FAILURE DISEASES | 2017-03-02 |
20170056373 | GHRELIN O-ACYLTRANSFERASE INHIBITORS | 2017-03-02 |
20170056374 | Fast Acting Orally Disintegrating Film | 2017-03-02 |
20170056375 | PHARMACEUTICAL COMPOSITION | 2017-03-02 |
20170056376 | SELECTIVE ACTIVATORS OF THE INTERMEDIATE CONDUCTANCE CA2+ACTIVATED K+ CHANNEL KCa3.1 AND THEIR METHODS OF USE | 2017-03-02 |
20170056378 | METHOD OF INHIBITING CANCER CELL, METHOD FOR DETECTING CANCER CELL, AND SYSTEM FOR DETECTING CANCER CELL | 2017-03-02 |
20170056379 | METHOD OF USING DOPAMINE REUPTAKE INHIBITORS AND THEIR ANALOGS FOR TREATING DIABETES SYMPTOMS AND DELAYING OR PREVENTING DIABETES-ASSOCIATED PATHOLOGIC CONDITIONS | 2017-03-02 |
20170056380 | Systems, Methods, Techniques, and Compounds in Research and Treatment of Portal Hypertension and other Conditions | 2017-03-02 |
20170056381 | PYRIDOXAMINE FOR THE TREATMENT OF SICKLE CELL DISEASE, THALASSEMIA AND RELATED BLOOD DISEASES | 2017-03-02 |
20170056382 | COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | 2017-03-02 |
20170056383 | TOPICAL HERPES PAIN TREATMENT AND COMPOSITION | 2017-03-02 |
20170056384 | Regimens For Treating And Preventing Lysosomal Disorders And Degenerative Disorders Of The Central Nervous System | 2017-03-02 |
20170056385 | Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions | 2017-03-02 |
20170056386 | TOPICAL ANTIFUNGAL COMPOSITION FOR TREATING ONYCHOMYCOSIS | 2017-03-02 |
20170056387 | 5-HT4 RECEPTOR AGONIST FOR GASTROPARESIS | 2017-03-02 |
20170056388 | MODULATORS OF METHYL MODIFYING ENZYMES, COMPOSITIONS AND USES THEREOF | 2017-03-02 |
20170056389 | 5-AMINOPYRAZOLE-4-CARBOXAMIDE INHIBITORS OF CDPK1 FROM T. GONDII AND C. PARVUM | 2017-03-02 |
20170056390 | IDENTIFICATION OF NATURAL SMALL-MOLECULES AMPK ACTIVATORS FOR TREATMENT OF CANCERS OR MULTIDRUG-RESISTANT CANCERS | 2017-03-02 |
20170056391 | COMBINATION THERAPY COMPOSITIONS AND METHODS FOR TREATING CANCERS | 2017-03-02 |
20170056392 | COMPOSITIONS OF BUPRENORPHINE AND u ANTAGONISTS | 2017-03-02 |
20170056393 | METHOD OF PROVIDING SUSTAINED ANALGESIA WITH BUPRENORPHINE | 2017-03-02 |
20170056395 | USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY | 2017-03-02 |
20170056396 | ANTICOAGULANT REVERSAL AGENTS | 2017-03-02 |
20170056397 | SELECTIVE HISTAMINE H4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF VESTIBULAR DISORDERS | 2017-03-02 |
20170056398 | SUBSTITUTED PYRIDINES AS P2X3 AND P2X2/3 ANTAGONISTS | 2017-03-02 |
20170056399 | SUSTAINED DRUG DELIVERY IMPLANT | 2017-03-02 |
20170056400 | NOVEL THERAPEUTIC USE OF P75 RECEPTOR ANTAGONISTS | 2017-03-02 |
20170056401 | STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN | 2017-03-02 |
20170056402 | HISTONE DEACETYLASE 6 INHIBITION FOR ENHANCING T-CELL FUNCTION DURING ANTI-TUMOR RESPONSE AND TUMOR-PEPTIDE VACCINATION | 2017-03-02 |
20170056403 | METHODS OF ADMINISTERING ELAGOLIX | 2017-03-02 |
20170056404 | COMBINATION OF NELFINAVIR, METFORMIN AND ROSUVASTATIN FOR TREATING CANCER CAUSED BY ABERRATIONS IN PTEN/TP53 | 2017-03-02 |
20170056405 | METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTION | 2017-03-02 |
20170056406 | METHOD FOR TREATING CANCER | 2017-03-02 |
20170056407 | RISPERIDONE SUSTAINED RELEASE MICROSPHERE COMPOSITION | 2017-03-02 |
20170056408 | MEDICAMENT FOR TREATING PERIPHERAL NEUROPATHIES | 2017-03-02 |
20170056409 | CARM1 INHIBITORS AND USES THEREOF | 2017-03-02 |
20170056410 | Compositions Useful for Treating Herpes Simplex Keratitis, and Methods Using Same | 2017-03-02 |
20170056411 | MODIFIED RELEASE PREPARATIONS CONTAINING OXCARBAZEPINE AND DERIVATIVES THEREOF | 2017-03-02 |
20170056412 | PROSTAMIDE-CONTAINING INTRAOCULAR IMPLANTS AND METHODS OF USE THEREOF | 2017-03-02 |
20170056413 | Compounds That Modulate Oxidative Stress | 2017-03-02 |
20170056414 | METHODS AND COMPOSITIONS COMPRISING URSOLIC ACID AND/OR RESVERATROL FOR TREATING DIABETES, OR CANCER | 2017-03-02 |
20170056415 | BIOAVAILABLE SOLID STATE (17-.beta.)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS | 2017-03-02 |
20170056416 | STEROID COMPOUND FOR USE IN THE TREATMENT OF HEPATIC ENCEPHALOPATHY | 2017-03-02 |
20170056417 | METHOD FOR SCHEDULING OVULATION | 2017-03-02 |
20170056418 | FORMULATIONS FOR SOLUBILIZING HORMONES | 2017-03-02 |
20170056419 | Methods and Compositions for Inhibiting Clostridium difficile Spore Germination and Outgrowth | 2017-03-02 |
20170056420 | TRITERPENOIDS WITH HIV MATURATION INHIBITORY ACTIVITY | 2017-03-02 |
20170056421 | COMPOSITIONS AND METHODS FOR INHIBITING ANTIAPOPTOTIC Bcl-2 PROTEINS AS ANTI-AGING AGENTS | 2017-03-02 |
20170056422 | PLASMODIUM LIVER-STAGE INHIBITORS AND RELATED METHODS | 2017-03-02 |
20170056423 | COMBINATION THERAPY COMPRISING TENOFOVIR ALAFENAMIDE HEMIFUMARATE AND COBICISTAT FOR USE IN THE TREATMENT OF VIRAL INFECTIONS | 2017-03-02 |
20170056424 | SOLID FORMS OF TENOFOVIR | 2017-03-02 |
20170056425 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2017-03-02 |
20170056426 | COMPOSITIONS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING COMPLEX REGIONAL PAIN SYNDROME | 2017-03-02 |
20170056427 | DOSAGE FORMS FOR ORAL ADMINISTRATION OF ZOLEDRONIC ACID OR RELATED COMPOUNDS FOR TREATING DISEASE | 2017-03-02 |
20170056428 | Compounds for the Treatment of Medical Disorders | 2017-03-02 |
20170056429 | PRODRUG COMPOUNDS AND THEIR USES | 2017-03-02 |
20170056430 | Methods and Compositions for Treating Cancers and Enhancing Therapeutic Immunity by Selectively Reducing Immunomodulatory M2 Monocytes | 2017-03-02 |
20170056431 | APPLICATION OF FRUCTUS SCHISANDRAE TOTAL POLYSACCHARIDES IN PREPARATOIN OF MEDICINE OR NUTRACEUTICALS USED FOR TREATING COUGHING | 2017-03-02 |